RBM5 and colonic neoplasm: According to previous studies, RBM5-AS1 promotes self-renewal properties of colon cancer stem cells [9], and exerts pro-oncogenic effects in osteosarcoma, hepatoma, and oral squamous cell carcinoma [10–12].